Xingcheng Yang, Lijun Jiang, Xiaoying Zhang, Juan Peng, Hu Qian, Lifang Huang, . . . Jia Wei. (2024). Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes. BMC.
Chicago Style (17th ed.) CitationXingcheng Yang, et al. Soluble PD-L1 as a Novel Biomarker Predicts Poor Outcomes and Disease Progression in De Novo Myelodysplastic Syndromes. BMC, 2024.
MLA (9th ed.) CitationXingcheng Yang, et al. Soluble PD-L1 as a Novel Biomarker Predicts Poor Outcomes and Disease Progression in De Novo Myelodysplastic Syndromes. BMC, 2024.
Warning: These citations may not always be 100% accurate.